Similarly, as important fibrotic markers, α-SMA, TGF-β, COL1A1, and desmin expression was also inhibited by KXRG treatment, thus inhibiting hepatic fibrosis. This evidence concerns the gene TGFB1 and Hepatic fibrosis.